AP-601

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAP-601

Drug Alias NameAP-601

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-5'-nucleotidaseAnti-Tumor necrosis factor receptor superfamily member 9

Targets5'-nucleotidaseTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAP Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAP Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A